SCHEMBL27375511

SCHEMBL27375511

NCc1cc(F)cc(Nc2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
MTOR P42345 1/20 0.39
MAOB P27338 2/20 0.39
PPARA Q07869 1/20 0.39
KDR P35968 2/20 0.37
EGFR P00533 1/20 0.37
PDGFRB P09619 1/20 0.37
DHODH Q02127 1/20 0.37
FLT1 P17948 1/20 0.37
KIF11 P52732 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
EPHX2 P34913 1/20 0.36
EPAS1 Q99814 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456939 1.00 SOS1 (0.41) SOS1TRPV1TAAR1MTORMAOB
SCHEMBL27374959 0.85 LOXL2 (0.48) SOS1TAAR1MAOBEGFRMEN1
SCHEMBL31456969 0.85 LOXL2 (0.48) SOS1TAAR1MAOBEGFRMEN1
SCHEMBL27374863 0.84 KIF11 (0.48) TAAR1KIF11KDM4EALDH1A1GAA
SCHEMBL31456953 0.84 KIF11 (0.48) TAAR1KIF11KDM4EALDH1A1GAA
SCHEMBL31456993 0.81 LOXL2 (0.44) SOS1TAAR1KDRFLT1KDM4E
SCHEMBL27374825 0.81 LOXL2 (0.44) SOS1TAAR1KDRFLT1KDM4E
SCHEMBL31457034 0.80 HSD17B10 (0.43) SOS1TAAR1MAOBKDM4EMEN1
SCHEMBL27374802 0.80 HSD17B10 (0.43) SOS1TAAR1MAOBKDM4EMEN1
SCHEMBL30751434 0.77 ALDH1A1 (0.40) SOS1CA1CA2MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024030000-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 넥스트젠바이오사이언스 2024-02-08 WO disclosed